To include your compound in the COVID-19 Resource Center, submit it here.

Celltech Group, Pharmacia deal

CCH received an exclusive U.S. license from PHA to market and distribute Dipentum osalazine capsules to treat

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE